Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Micro-dosing ICG for Intraoperative Perfusion Assessment in Children
NCT06421103Recruiting
- Sponsor
- Great Ormond Street Hospital
- Start
- Jun 2024
- Primary completion
- Aug 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of indocyanine green in gastrointestinal tract disorders and Genitourinary disorder, sponsored by Great Ormond Street Hospital. Primary endpoints: Minimum clinically useful dose of ICG in children at 60 minutes and Number of adverse drug events at each dose level at 30 days. Started Jun 2024; status: recruiting.
02
Drugs
indocyanine green
03
Conditions
gastrointestinal tract disordersGenitourinary disorder
Beyond the preview
Go deeper on NCT06421103.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06421103.